Given that p-Src is induced by different types of growth factors, hormone, and integrin receptors in cancer cells, the lack of its inhibition by MH suggests that the latter does not interfere with ligand binding to multiple receptor types, including PDGF-R, EGF-R, FGF-R, VEGF-R, and IGF-1R [34]. Here, SRC is linked to cancer.